Proton pump inhibitors vs h2 blockers

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Proton Pump Inhibitors vs. H2 Blockers: A Comparative Analysis

Introduction to Proton Pump Inhibitors and H2 Blockers

Proton pump inhibitors (PPIs) and histamine-2 receptor blockers (H2RBs) are commonly used medications for managing acid-related gastrointestinal conditions. Both classes of drugs are effective in reducing stomach acid, but they differ in their mechanisms of action and potential side effects.

Efficacy in Stress Ulcer Prophylaxis

Mortality and Upper Gastrointestinal Bleeding

The PEPTIC study, a large-scale clinical trial, compared the use of PPIs and H2RBs for stress ulcer prophylaxis in ICU patients. The study found no significant difference in in-hospital mortality between the two groups, with mortality rates of 18.3% for PPIs and 17.5% for H2RBs . However, PPIs were associated with a lower incidence of clinically significant upper gastrointestinal bleeding compared to H2RBs (1.3% vs. 1.8%) .

Meta-Analysis Findings

An updated meta-analysis incorporating the PEPTIC trial data suggested that PPIs might increase mortality compared to H2RBs, with a pooled relative risk of 1.05 . This finding aligns with another study that reported a higher risk of death among PPI users compared to H2RB users, particularly in a cohort of U.S. veterans .

Safety Concerns

Risk of Dementia

A meta-analysis investigating the potential link between PPIs, H2RBs, and dementia found no significant difference in dementia risk between users and non-users of these medications . This suggests that neither PPIs nor H2RBs are independently associated with an increased risk of dementia.

Iron Absorption and Gut Microbiota

PPIs have been shown to affect iron metabolism by increasing hepcidin levels, which in turn inhibits iron absorption . Additionally, PPIs can alter the gut microbiota, potentially increasing the proliferation of certain bacteria like Escherichia coli and Lactobacillus rhamnosus, while inhibiting others such as Blastocystis and Candida albicans . H2RBs, on the other hand, do not appear to have a significant impact on these microorganisms .

Clinical Implications and Recommendations

Critical Care Settings

In critical care settings, the choice between PPIs and H2RBs for stress ulcer prophylaxis should consider both efficacy and safety profiles. While PPIs may offer better protection against upper gastrointestinal bleeding, they are associated with a slightly higher risk of mortality and other adverse effects 345.

Long-Term Use and Specific Populations

For long-term use, particularly in populations such as kidney transplant recipients, the safety profile of H2RBs may be more favorable. A systematic review and meta-analysis highlighted the need for careful consideration of adverse effects in these patients .

Conclusion

Both PPIs and H2RBs have their advantages and limitations. PPIs are more effective in preventing upper gastrointestinal bleeding but may carry a higher risk of mortality and other adverse effects. H2RBs, while slightly less effective in acid suppression, may offer a safer profile for long-term use. Clinicians should weigh these factors when prescribing these medications, tailoring their choice to the specific needs and risks of their patients.

Sources and full results

Most relevant research papers on this topic

A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.

The PEPTIC study aims to compare the effect of using proton pump inhibitors (PPIs) as the preferred agent for stress ulcer prophylaxis in mechanically ventilated adults in ICU with using histamine-2 receptor blockers (H2RBs) as the preferred agent on in-hospital mortality.

RCT

2018·

16citations

·P. Young et al.

Possible dementia risk of proton pump inhibitors and H2 receptor blockers use in the treatment of Helicobacter pylori: A meta-analysis study.

Using PPIs or H2-receptor-blockers for Helicobacter pylori treatment is not related to dementia, but careful use and adherence to treatment duration is still recommended.

Meta-Analysis

2020·

6citations

·Yongzhen Zhang et al.

Proton pump inhibitors vs. histamine-2 receptor antagonists likely increase mortality in critical care: an updated meta-analysis.

Stress ulcer prophylaxis with PPIs likely increases mortality compared to H2RAs in critically ill patients.

Meta-Analysis

2020·

7citations

·Todd C Lee et al.

Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.

Preferential use of PPIs for stress ulcer prophylaxis in ICU patients receiving invasive mechanical ventilation reduces in-hospital mortality rates compared to H2RBs.

RCTLarge Human TrialHighly Cited

2020·

135citations

·P. Young et al.

Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans

PPI use is associated with an increased risk of death, particularly among those without gastrointestinal conditions and those with prolonged duration of use.

Observational StudyRigorous JournalHighly Cited

2017·

199citations

Comparative Effectiveness of Proton Pump Inhibitors vs Histamine Type 2 Receptor Blockers for Preventing Clinically Important Gastrointestinal Bleeding During Intensive Care: A Population‐Based Study

H2Bs are significantly associated with lower clinically important gastrointestinal bleeding risk compared to PPIs in critically ill adults.

Observational Study

2018·

29citations

·C. Lilly et al.

Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway.

Proton pump inhibitors directly affect iron metabolism by suppressing iron absorption through the inhibition of duodenal ferroportin via hepcidin upregulation.

In Vitro Study

2019·

27citations

·H. Hamano et al.

Future prospects for proton pump inhibitors

Proton pump inhibitors show potential in healing duodenal and gastric ulcers, providing faster relief and fewer side-effects than H2 blockers, with potential for future use in acid peptic disorders.

1993·

7citations

·J. Freston

Comparing safety of proton‐pump inhibitors versus H2‐receptor antagonists in kidney transplant recipients: A systematic review and meta‐analysis

Proton-pump inhibitors (PPIs) show a lower risk of adverse effects compared to H2 receptor antagonists (H2RAs) in kidney transplant recipients.

Meta-AnalysisRigorous Journal

2021·

1citation

·Keyhan Mohammadi et al.

Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro

Pantoprazole and esomeprazole effectively inhibit Blastocystis and C. albicans, while pantoprazole increases L. rhamnosus and E. coli proliferation, while H2 blockers show no significant effect on these microorganisms.

In Vitro StudyVery Rigorous Journal

2021·

1citation

·M. Lepczyńska et al.

Try another search

tagamet generic name

potassium sparing diuretics

machine learning development

proair digihaler vs hfa

can i use spring water for baby formula

what year was the warmest year on record